Prior to the publication of the 5th WHO classification system for CNS tumors, which integrated IDH status to the molecular diagnostic criteria for glioblastoma, an IDH-wildtype status has also been associated with a higher risk of spinal metastasis [47,56]. Here, IDH1 is linked to central nervous system neoplasm.